Cargando…

Clinical view versus guideline adherence in ferritin monitoring and initiating iron chelation therapy in patients with myelodysplastic syndromes

OBJECTIVES: In patients with myelodysplastic syndromes (MDS) with >20 transfusions and ferritin levels >1000 μg/L, international guidelines recommend iron chelation therapy (ICT). The study's objective was to determine guideline adherence and the intensity of ferritin monitoring in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rozema, Johanne, van Asten, Ivar, Kwant, Beau, Kibbelaar, Robby E., Veeger, Nic J. G. M., de Wit, Harry, van Roon, Eric N., Hoogendoorn, Mels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828450/ https://www.ncbi.nlm.nih.gov/pubmed/36130872 http://dx.doi.org/10.1111/ejh.13865

Ejemplares similares

Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web‐based case vignette questionnaire: The MINDSET study
por: Rozema, Johanne, et al.
Publicado: (2022)

Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population‐based study
por: Rozema, Johanne, et al.
Publicado: (2021)

Increased prescription rate of anti‐infective agents after diagnosis of myelodysplastic syndromes
por: Rozema, Johanne, et al.
Publicado: (2022)

Effectiveness of a vitamin D regimen in deficient multiple myeloma patients and its effect on peripheral neuropathy
por: Oortgiesen, Berdien E., et al.
Publicado: (2023)

Relapse in stage I(E) diffuse large B‐cell lymphoma
por: Nijland, Marcel, et al.
Publicado: (2017)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Characterisation of individual ferritin response in patients receiving chelation therapy
por: Borella, Elisa, et al.
Publicado: (2022)

High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study
por: Oortgiesen, B. E., et al.
Publicado: (2021)

Non-invasive bladder volume measurement for the prevention of postoperative urinary retention: validation of two ultrasound devices in a clinical setting
por: Brouwer, Tammo A., et al.
Publicado: (2018)

Optimizing Communication and Adherence to Iron Chelation Therapy From Diagnosis to Treatment in Patients With Myelodysplastic Syndromes
por: Shah, Jayshree, et al.
Publicado: (2016)

Effect of nadroparin on anti-Xa activity during nocturnal hemodialysis
por: Buitenwerf, Edward, et al.
Publicado: (2015)

Primary Epstein–Barr virus infection diffusing F(18)-fluorodeoxyglucose-positron emission tomography/computed tomography response monitoring of Hodgkin’s disease: a case report
por: Balink, Hans, et al.
Publicado: (2014)

Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients
por: Parisi, Sarah, et al.
Publicado: (2021)

A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic Syndromes
por: Oliva, Esther Natalie, et al.
Publicado: (2022)

Native aortic valve endocarditis with Morganella morganii in a patient with multiple myeloma and valvular amyloidosis: a case report
por: van Bentum, Renée, et al.
Publicado: (2019)

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
por: Gattermann, Norbert
Publicado: (2008)

Role of iron chelation in improving survival: An integral part of current therapy for myelodysplastic syndromes
por: Taran, Sachi Jain, et al.
Publicado: (2015)

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
por: Hoeks, Marlijn, et al.
Publicado: (2020)

Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea
por: Lee, Jong Wook
Publicado: (2008)

Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome
por: Badawi, Maha A., et al.
Publicado: (2010)

Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes
por: Park, Sophie, et al.
Publicado: (2019)

Role of serum ferritin level on overall survival in patients with myelodysplastic syndromes: Results of a meta-analysis of observational studies
por: Pileggi, Claudia, et al.
Publicado: (2017)

Effect of supplementation with ferrous sulfate or iron bis-glycinate chelate on ferritin concentration in Mexican schoolchildren: a randomized controlled trial
por: Duque, Ximena, et al.
Publicado: (2014)

Myelodysplastic syndrome from theoretical review to clinical application view
por: Mohammad, Amrallah A.
Publicado: (2018)

Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR
por: Schulz, Felicitas, et al.
Publicado: (2023)

Is the time in therapeutic range on coumarins predicted by previous time in therapeutic range?
por: van Miert, Jasper H. A., et al.
Publicado: (2020)

Bortezomib maintenance after R‐CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial
por: Doorduijn, Jeanette K., et al.
Publicado: (2020)

Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy
por: Pinto, Valeria, et al.
Publicado: (2015)

The fate of Gd and chelate following intravenous injection of gadodiamide in rats
por: Kindberg, Grete Mørk, et al.
Publicado: (2010)

Validation of a Fully Automated HER2 Staining Kit in Breast Cancer
por: Moelans, Cathy B., et al.
Publicado: (2010)

The relationship of weight change trajectory with medial temporal lobe atrophy in patients with mild Alzheimer’s disease: results from a cohort study
por: Droogsma, Erika, et al.
Publicado: (2015)

Assessment methods in laparoscopic colorectal surgery: a systematic review of available instruments
por: van Zwieten, Tom, et al.
Publicado: (2023)

TIM-2 soaks up ferritin
por: Van Epps, Heather L.
Publicado: (2005)

Fatal Cobalt Toxicity after a Non-Metal-on-Metal Total Hip Arthroplasty
por: Peters, Rinne M., et al.
Publicado: (2017)

Effect of the Ginger Derivative, 6-Shogaol, on Ferritin Levels in Patients With Low to Intermediate-1–Risk Myelodysplastic Syndrome—A Small, Investigative Study
por: Golombick, Terry, et al.
Publicado: (2017)

Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis
por: van Miert, Jasper H. A., et al.
Publicado: (2018)

Serum ferritin levels and irregular use of iron chelators predict liver iron load in patients with major beta thalassemia: a cross-sectional study
por: Sobhani, Soheila, et al.
Publicado: (2019)

Postoperative urinary retention: risk factors, bladder filling rate and time to catheterization: an observational study as part of a randomized controlled trial
por: Brouwer, Tammo A., et al.
Publicado: (2021)

Advances on Chelation and Chelator Metal Complexes in Medicine †
por: Kontoghiorghes, George J.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3m0mkipaod424o66f8ggk9gn8r